
Last 4 earnings calls · through Q2 FY2026
The bull case is that a long run of large-deal signings is now moving into execution, so second-half revenue comes from contracts already won rather than from new client budgets.
Banks and insurers are spending on AI and legacy modernization again, and management treats that recovery as a leading indicator that other industries will follow.
Cost programs and a broader base of junior staff are expected to keep lifting operating margin even as acquisitions, merit increases and bonuses add expense.
The bear case is that clients keep postponing short, discretionary projects, so large-deal wins largely replace revenue that is being lost rather than adding to it.
Productivity gains from AI are handed to clients as lower prices per unit of work, which caps revenue growth even while delivery costs fall.
Management has already trimmed the top of its full-year revenue range and no longer assumes that discretionary spending recovers during the year.
Buybacks and an acquisition have turned a net cash position into net debt, so capital returns now depend on cash generation holding up.
In short: Large-deal bookings are strong, while short-cycle discretionary work keeps shrinking.
Bookings rose 21% in the first quarter on seven deals above $100 million, and management says those contracts ramp through the second half, giving revenue visibility that short-cycle work does not.
Banking and insurance clients are funding AI and legacy modernization work again, and this is Cognizant's largest segment, so its double-digit growth carries total company revenue.
In April management still guided to 4% to 6.5% constant-currency growth for 2026; in July it cut the top of that range to 5.5% and said macro uncertainty had stayed elevated instead of easing.
Annual contract value fell modestly as deal durations lengthened and small discretionary projects stayed weak, which trims the revenue that renews on a short cycle.
In short: Operating margin expands and cash flow is strong, while gross margin slipped and buybacks drew on debt.
In February management guided 2026 operating margin to 15.9%-16.1%, a 10 to 30 basis point expansion; in April it raised the range to 16%-16.2% after budgeting $200 million to $300 million of LEAP savings.
Operating margin reached 15.9% in the second quarter, up 0.4 points, as cost discipline and rupee depreciation offset salary increases and dilution from acquisitions.
Gross margin slipped to 33.4% as integrated offerings that resell third-party products and higher compensation raised delivery costs; those pass-through sales add revenue at thin margin.
Cognizant returned $3.0 billion over the past year, more than it generated in free cash flow, and borrowed $1 billion under a credit line, leaving net debt of $509 million and higher interest expense.
In short: TriZetto anchors healthcare, while AI productivity is passed to clients as lower prices.
The healthcare platform business generates more than $1.1 billion of annual revenue, grows faster than the company and earns higher margins, anchoring Cognizant in claims administration software and the operations around it.
Outcome-based contracts let Cognizant keep part of the productivity gain instead of billing hours, which supports pricing and margin as AI reduces the labor needed per project.
Management describes persistent productivity-led price pressure across the industry, so Cognizant must keep cutting delivery cost just to hold revenue per project flat.
Healthcare is 29% of segment revenue but grew only 1.4%, as health sciences clients hold back discretionary spend and regulation of government payer programs clouds their budgets.